Year |
Citation |
Score |
2016 |
Darpan D, Joshi G, Amrutkar SM, Baviskar AT, Kler H, Singh S, Banerjee UC, Kumar R. Synthesis and biological evaluation of new 2,5-dimethylthiophene/furan based N-acetyl pyrazolines as selective topoisomerase II inhibitors Rsc Advances. 6: 14880-14892. DOI: 10.1039/C5Ra25705K |
0.716 |
|
2015 |
Negi A, Alex JM, Amrutkar SM, Baviskar AT, Joshi G, Singh S, Banerjee UC, Kumar R. Imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via selective topoisomerase-II-α inhibition. Bioorganic & Medicinal Chemistry. PMID 26216018 DOI: 10.1016/J.Bmc.2015.07.020 |
0.714 |
|
2015 |
Baviskar AT, Amrutkar SM, Trivedi N, Chaudhary V, Nayak A, Guchhait SK, Banerjee UC, Bharatam PV, Kundu CN. Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic Inhibitors. Acs Medicinal Chemistry Letters. 6: 481-5. PMID 25941559 DOI: 10.1021/Acsmedchemlett.5B00040 |
0.662 |
|
2013 |
Baviskar AT, Banerjee UC, Gupta M, Singh R, Kumar S, Gupta MK, Kumar S, Raut SK, Khullar M, Singh S, Kumar R. Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity. Bioorganic & Medicinal Chemistry. 21: 5782-93. PMID 23920485 DOI: 10.1016/j.bmc.2013.07.016 |
0.347 |
|
2013 |
Kashyap M, Kandekar S, Baviskar AT, Das D, Preet R, Mohapatra P, Satapathy SR, Siddharth S, Guchhait SK, Kundu CN, Banerjee UC. Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents. Bioorganic & Medicinal Chemistry Letters. 23: 934-8. PMID 23321564 DOI: 10.1016/J.Bmcl.2012.12.063 |
0.704 |
|
2013 |
Singh S, Baviskar AT, Jain V, Mishra N, Chand Banerjee U, Bharatam PV, Tikoo K, Singh Ishar MP. 3-Formylchromone based topoisomerase IIα inhibitors: discovery of potent leads Medchemcomm. 4: 1257. DOI: 10.1039/C3MD00125C |
0.482 |
|
2011 |
Baviskar AT, Madaan C, Preet R, Mohapatra P, Jain V, Agarwal A, Guchhait SK, Kundu CN, Banerjee UC, Bharatam PV. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase. Journal of Medicinal Chemistry. 54: 5013-30. PMID 21644529 DOI: 10.1021/Jm200235U |
0.709 |
|
Show low-probability matches. |